-- GlaxoSmithKline Posts Third-Quarter Profit of $2.3 Billion, Above Estimate
-- B y   A l b e r t i n a   T o r s o l i
-- 2010-10-21T11:01:23Z
-- http://www.bloomberg.com/news/2010-10-21/glaxosmithkline-posts-third-quarter-profit-of-2-3-billion-above-estimate.html
GlaxoSmithKline Plc, the U.K.â€™s
largest drugmaker, reported third-quarter profit excluding some
items of 1.44 billion pounds, or 28.2 pence a share. That beat
the average estimate of 27.3 pence a share from 14 analysts
surveyed by Bloomberg.  To contact the editor responsible for this story:
Kristen Hallam at 
 khallam@bloomberg.net  